This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Cell Therapeutics, Inc.. Active years: 2012.
Company Filing History:
Years Active: 2012
Title: Holly Spoonemore: Innovator in Taxane Conjugate Analysis
Introduction
Holly Spoonemore is a notable inventor based in Bellevue, WA (US). She has made significant contributions to the field of biochemistry, particularly in the analysis of taxane conjugates. Her innovative work has led to the development of a patented method that enhances the understanding of drug formulations.
Latest Patents
Holly Spoonemore holds a patent for a "Method for determining the amount of conjugated taxane in polyglutamic acid-taxane conjugates." This invention relates to a method for determining the amount of conjugated taxane, specifically paclitaxel, in a PGA-taxane conjugate. The method involves reacting the PGA-taxane conjugate with a specific compound to yield unbound taxane and a PGA hydrazide, followed by determining the amount of unbound taxane. This patent represents a significant advancement in the field of drug delivery systems.
Career Highlights
Throughout her career, Holly has worked with prominent companies such as Cell Therapeutics, Inc. and Cell Therapeutics Europe S.r.l. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Holly has had the opportunity to work alongside esteemed colleagues, including Stefano Fazioni and Keith Hovda. These collaborations have further enriched her research and innovation in the field of taxane conjugates.
Conclusion
Holly Spoonemore's contributions to the field of biochemistry, particularly through her patented method for analyzing taxane conjugates, highlight her role as an influential inventor. Her work continues to impact the development of effective drug delivery systems.